Literature DB >> 15085537

Estrogen increases calcitonin gene-related peptide-immunoreactive sensory innervation of rat mammary gland.

A D Blacklock1, P G Smith.   

Abstract

Estrogen plays important roles in preparing mammary tissue for lactation. However, estrogen also influences innervation in some tissues. We examined the effect of estrogen on peripheral innervation of mammary tissues of ovariectomized adult virgin female rats. Seven days after ovariectomy, 17beta-estradiol or placebo pellets were implanted subcutaneously, and tissues were harvested 1 week later. Estrogen treatment decreased mammary gland mass and adipocyte content, while ductal content increased and vascular composition was unaffected. Estrogen increased total areas occupied by nerves in mammary gland sections immunostained for the pan-neuronal marker protein gene product 9.5, and this increase persisted after normalizing for treatment-induced differences in gland mass. Although a significant increase in tyrosine hydroxylase-immunoreactive sympathetic nerve area was observed, no difference was detected following correction for differences in gland size, implying a conserved number of sympathetic nerves in the face of reduced gland volume. Calcitonin gene-related peptide-immunoreactive sensory nerve sectional area was also increased, and corrected nerve area remained 88% greater, indicating nerve proliferation during estrogen treatment. Total, sensory, and sympathetic innervation of the nipple and adjacent dermal tissue were unaffected by estrogen. We conclude that chronic estrogen elevation induces selective proliferation of rat mammary gland calcitonin gene-related peptide-containing nerves, which are associated primarily with blood vessels and are probably nociceptors. Because they are likely to subserve a vasodilatory function, increased innervation may promote increased blood flow necessary for milk formation during suckling. Moreover, these findings may help explain abundant anecdotal reports of increased breast sensitivity in humans under high estrogen conditions. Copyright 2004 Wiley Periodicals, Inc. J Neurobiol 59: 192-204, 2004

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15085537     DOI: 10.1002/neu.10310

Source DB:  PubMed          Journal:  J Neurobiol        ISSN: 0022-3034


  8 in total

Review 1.  Estrogen effects on neuronal morphology.

Authors:  Sonsoles de Lacalle
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

2.  Nerve-Langerhans cell interactions in diabetes and aging.

Authors:  A L N Doss; P G Smith
Journal:  Histol Histopathol       Date:  2012-12       Impact factor: 2.303

3.  Systemic and topical hormone therapies reduce vaginal innervation density in postmenopausal women.

Authors:  Tomas L Griebling; Zhaohui Liao; Peter G Smith
Journal:  Menopause       Date:  2012-06       Impact factor: 2.953

4.  Trophic factor and hormonal regulation of neurite outgrowth in sensory neuron-like 50B11 cells.

Authors:  Aritra Bhattacherjee; Zhaohui Liao; Peter G Smith
Journal:  Neurosci Lett       Date:  2013-11-20       Impact factor: 3.046

5.  Estrogen promotes sympathetic nerve regeneration in rat proximal urethra.

Authors:  Peter G Smith; Matthew George; Sarah Bradshaw
Journal:  Urology       Date:  2009-04-10       Impact factor: 2.649

6.  Angiotensin II receptor type 2 activation is required for cutaneous sensory hyperinnervation and hypersensitivity in a rat hind paw model of inflammatory pain.

Authors:  Anuradha Chakrabarty; Zhaohui Liao; Peter G Smith
Journal:  J Pain       Date:  2013-05-30       Impact factor: 5.820

7.  Long-term treatment with testosterone alters ovary innervation in adult pigs.

Authors:  Barbara Jana; Karolina A Meller; Michał Bulc; Jarosław Całka
Journal:  J Ovarian Res       Date:  2016-10-10       Impact factor: 4.234

8.  Estrogen elicits dorsal root ganglion axon sprouting via a renin-angiotensin system.

Authors:  Anuradha Chakrabarty; Audrey Blacklock; Stanislav Svojanovsky; Peter G Smith
Journal:  Endocrinology       Date:  2008-04-03       Impact factor: 4.736

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.